These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interleukin-17 promotes the development of ovarian cancer through upregulation of MTA1 expression. Guo N; Zhang J Am J Cancer Res; 2022; 12(12):5646-5656. PubMed ID: 36628289 [TBL] [Abstract][Full Text] [Related]
5. Erratum: HOXC10 promotes carboplatin resistance of ovarian cancer by regulating ABCC3. Li Y; Lei H; Hai R; Shu G; Yan W; Yin G Am J Cancer Res; 2024; 14(1):403-406. PubMed ID: 38323296 [TBL] [Abstract][Full Text] [Related]
6. Erratum: Interleukin-17 promotes the development of ovarian cancer through upregulation of MTA1 expression. Guo N; Zhang J Am J Cancer Res; 2023; 13(2):709-710. PubMed ID: 36895973 [TBL] [Abstract][Full Text] [Related]